The Fortune 500 Innovation Forum will convene Fortune 500 executives, U.S
Receiving warm semaglutide is a legitimate concern, and most reputable providers will replace compromised shipments
Women should not take GLP-1s or other weight loss medications while pregnant, breastfeeding, or trying to conceive
doi: 10.5603/NMR.2014.0022 23 Omar-HmeadiMLundPEGandasiNRTengholmABargS
Additionally, GLP-1 medications may alter how the kidneys handle electrolytes, creating a theoretical risk when combined with potassium-sparing agents
As noted by experts at the University of Connecticut, GLP-1 peptide molecules are too large to effectively penetrate the skin barrier, making transdermal delivery of actual GLP-1 medications currently impossible with existing technology